Robert Charles Breedlove - 05 Sep 2025 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Signature
/s/ Robert Charles Breedlove
Issuer symbol
PHAT
Transactions as of
05 Sep 2025
Net transactions value
-$5,573
Form type
4
Filing time
09 Sep 2025, 16:40:19 UTC
Previous filing
18 Jul 2025
Next filing
05 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Breedlove Robert Charles Principal Accounting Officer C/O PHATHOM PHARMACEUTICALS, INC., 100 CAMPUS DRIVE, SUITE 102, FLORHAM PARK /s/ Robert Charles Breedlove 09 Sep 2025 0002066645

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale $5,573 -461 -0.95% $12.09 47,931 05 Sep 2025 Direct F1
holding PHAT Common Stock 6,945 05 Sep 2025 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.